Cargando…
Video-Urodynamic Characteristics and Predictors of Switching from Botulinum Neurotoxin a Injection to Augmentation Enterocystoplasty in Spinal Cord Injury Patients
Botulinum neurotoxin type A (BoNT-A) injection and augmentation enterocystoplasty (AE) are alternative and effective management strategies for neurogenic detrusor overactivity (NDO) refractory to pharmacotherapy. A great majority of patients with spinal cord injury (SCI) may, however, prefer BoNT-A...
Autores principales: | Lin, Chih-Chieh, Kuo, Hann-Chorng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777902/ https://www.ncbi.nlm.nih.gov/pubmed/35051024 http://dx.doi.org/10.3390/toxins14010047 |
Ejemplares similares
-
Long-term Outcomes of Augmentation Enterocystoplasty in Patients With End-Stage Bladder Diseases: A Single-Institute Experience Involving 102 Patients
por: Wu, Shu-Yu, et al.
Publicado: (2017) -
Alternatives to Conventional Enterocystoplasty in Children: A Critical Review of Urodynamic Outcomes
por: González, Ricardo, et al.
Publicado: (2013) -
Clinical Application of Botulinum Neurotoxin in Lower-Urinary-Tract Diseases and Dysfunctions: Where Are We Now and What More Can We Do?
por: Kuo, Hann-Chorng
Publicado: (2022) -
The Comparative Effectiveness of Botulinum Toxin-A Injection Therapy Versus Augmentation Uretero-Enterocystoplasty for the Treatment of Lower Urinary Tract Dysfunction
por: Wang, Xuesheng, et al.
Publicado: (2023) -
Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
por: Chen, Sheng-Fu, et al.
Publicado: (2016)